Articles mentioning Gilead Sciences (GILD)

Results 81 - 90 of 757 : Previous 5 6 7 8 9 10 11 12 13 Next

Get RSS Feed for GILD

Investing | October 04, 2011

1 Reason the Street Should Love Gilead Sciences' Earnings

Don’t just count the cash, time it.

Investing | October 03, 2011

Amgen Passes Buffett's Test

Here's one of Buffett's favorite metrics for evaluating companies.

Investing | September 29, 2011

Are HIV Drugmakers Doomed?

Generics are a bigger threat than Sangamo for now.

Investing | September 28, 2011

One Step Closer to an FDA Decision

Cell Therapeutics is still risky, though.

Investing | September 28, 2011

Will Gilead Sciences Blow It Next Quarter?

Look here for a clue.

Investing | September 27, 2011

Here's How Amgen Is Making You So Much Cash

All cash flow is not created equal.

Investing | September 24, 2011

A Fool Looks Back

Disc throws and midnight buffets played more than a bit part this week.

Investing | September 23, 2011

How Long Does It Take to Make a Buck at Biogen Idec?

Don't just count the cash, time it.

Investing | September 20, 2011

Phase 3 + Phase 3 = Quad Approval

But will Gilead Sciences' new four-drug cocktail sell?

Investing | September 19, 2011

Something to Watch at Amgen

Look here for a clue.

Results 81 - 90 of 757 : Previous 5 6 7 8 9 10 11 12 13 Next

Get RSS Feed for GILD


Advertisement